Open original FDA record ↗Recall record
- FDA identifier
- Z-0068-2027
- Company in FDA record
- Illumina, Inc.
- FDA classification date
- Oct 1, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Retrospectively reported correction for an instrument intended for targeted sequencing of DNA libraries from human genomic DNA used with in vitro diagnostic assays has a server with a security vulnerability.
Source facts
- Action
- On 9/17/2024, and 1/16/2025 field safety notices were emailed to customers who were asked to take actions on webpage: https://support.illumina.com/support-content/bmc.html Customers were also asked to complete and return the Verification Form via email to techsupport@illumina.com This email can also be used to ask questions or to report potentially compromised servers.
- Initiated
- 2024-09-17
- Root cause
- Software design
- Distribution
- Worldwide - US Nationwide distribution in the states of TX, KS, NC, CA, UT, KA, MA, NJ, MD and the countries of Spain, South Korea, Japan, Australia, Italy, United Arab Emirates, Sweden, United Kingdom, Czech Republic, Singapore, Austria, Poland, France, Germany, Finland, Switzerland, Slovakia.
- Recall number
- Z-0068-2027
- Recall status
- Open, Classified
- CDRH record ID
- 221916
- FDA classified
- 2026-10-01
- Recall event number
- 99585